Genomics of addiction

Current Psychiatry Reviews

Volumn 6, Issue 2, 2010, Pages 122-134

  Bevilacqua, Laura ^a   Goldman, David ^a  

^a NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

Author keywords

Addiction; Gene x environment; Genomics; Heritability; Intermediate phenotypes; Review

Indexed keywords

ALCOHOL DEHYDROGENASE; ALCOHOL DEHYDROGENASE 1B; ALDEHYDE DEHYDROGENASE ISOENZYME 2; CATECHOL METHYLTRANSFERASE; CHRNA5 PROTEIN; MU OPIATE RECEPTOR AGONIST; MU OPIATE RECEPTOR ANTAGONIST; NALTREXONE; PROTEIN; UNCLASSIFIED DRUG;

ADDICTION; ALCOHOLISM; ALLELE; ARTICLE; BEHAVIOR CONTROL; COGNITION; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; EPIGENETICS; GENE EXPRESSION; GENE INTERACTION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC LINKAGE; GENOMICS; HERITABILITY; HUMAN; IMPULSIVENESS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REWARD; SIGNAL TRANSDUCTION; STRESS; SUBSTANCE ABUSE; TOBACCO DEPENDENCE; TREATMENT RESPONSE;

EID: 77952519040     PISSN: 15734005     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340010791196411     Document Type: Article

References (148)

1. Goldman D, Oroszi G, Ducci F. The genetics of addictions: uncov-ering the genes. Nat Rev Genet 2005; 6: 521-32.
2. Goldstein A, Kalant H. Drug policy: striking the right balance. Science 1990; 249: 1513-21.
3. Li MD, Cheng R, Ma JZ, Swan GE. A meta-analysis of estimated genetic and environmental effects on smoking behavior in male and female adult twins. Addiction 2003; 98: 23-31.
4. Kendler KS, Karkowsky LM, Neale MC, Prescott CA. Illicit psy-choactive substance abuse, heavy use, abuse and dependence in a US population-based sample of male twins. Arch Gen Psychiatry 2000; 57: 261-69.
5. Kendler KS, Schmitt E, Aggen SH, Prescott CA. Genetic and envi-ronmental influences on alcohol, caffeine, cannabis, and nicotine use from early adolescence to middle adulthood. Arch Gen Psy-chiatry 2008; 65: 674-82.
6. Goldman D, Bergman A. General and specific inheritance of sub-stance abuse and alcoholism. Arch Gen Psychiatry 1998; 55: 964-65.
7. Swan GE, Carmelli D, Cardon LR. Heavy consumption of ciga-rettes, alcohol and coffee in male twins. J Stud Alcohol 1997; 58:182-90.
8. Hettema JM, Corey LA, Kendler KS. A multivariate genetic analy-sis of the use of tobacco, alcohol, and caffeine in a populationbased sample of male and female twins. Drug Alcohol Depend 1999; 57: 69-78.
9. Hopfer CJ, Stallings MC, Hewitt JK. Common genetic and envi-ronmental vulnerability for alcohol and tobacco use in a volunteersample of older female twins. J Stud Alcohol 2001; 62: 717-23.
10. True WR, Xian H, Scherrer JF, et al. Common genetic vulnerabil-ity for nicotine and alcohol dependence in men. Arch Gen Psychia-try 1999; 56: 655-61.
11. Koopmans JR, van Doornen LJ, Boomsma DI. Association be-tween alcohol use and smoking in adolescent and young adulttwins: a bivariate genetic analysis. Alcohol Clin Exp Res 1997; 21:537-46.
12. Burling TA, Ziff DC. Tobacco smoking: a comparison betweenalcohol and drug abuse inpatients. Addict Behav 1988; 13: 185-90.
13. DiFranza JR, Guerrera MP. Alcoholism and smoking. J Stud Alco-hol 1990; 51: 130-5.
14. Slutske WS, Eisen S, True WR, Lyons MJ, Goldberg J, Tsuang M.Common genetic vulnerability for pathological gambling and alco-hol dependence in men. Arch Gen Psychiatry 2000; 57: 666-73.
15. Harada S, Agarwal DP, Goedde HW. Aldehyde dehydrogenase deficiency as cause of facial flushing reaction to alcohol in Japa-nese. Lancet 1981; 2: 982.
16. Eriksson CJ. The role of acetaldehyde in the actions of alcohol (update 2000). Alcohol Clin Exp Res 2001; 25: 15S-32S.
17. Goldman D, Enoch MA. Genetic epidemiology of ethanol meta-bolic enzymes: a role for selection. World Rev Nutr Diet 1990; 63:143-60.
18. Brooks PJ, Goldman D, Li TK. Alleles of alcohol and acetaldehydemetabolism genes modulate susceptibility to oesophageal cancerfrom alcohol consumption. Hum Genomics 2009; 3: 103-5.
19. Seitz HK, Stickel F: Molecular mechanisms of alcohol-mediated carcinogenesis. Nat Rev Cancer 2007; 7: 599.
20. Brooks PJ, Enoch MA, Goldman D, Li TK, Yokoyama A. Thealcohol flushing response: an unrecognized factor for esophagealcancer from alcohol consumption. PLoS Med 2009; 3: e50.
21. Grant BF, Hasin DS, Chou SP, Stinson FS, Dawson DA. Nicotine dependence and psychiatric disorders in the United States: resultsfrom the national epidemiologic survey on alcohol and related con-ditions. Arch Gen Psychiatry 2004; 61: 1107-15.
22. CDC. Tobacco use among adults-United States, 2005. Morbid Mortal Wkly Rep 2006; 55: 1145-48.
23. Carmelli D, Swann G, Robinetter D, Fabsitz R. Genetic influence on smoking- a study of male twins. N Engl J Med 1992; 327: 829-33.
24. Gotti C, Zoli M, Clementi F. Brain nicotinic acetylcholine recep-tors: native subtypes and their relevance. Trends Pharmacol Sci 2006; 27: 482-91.
25. Picciotto MR, Zoli M, Rimondini R, et al. Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing proper-ties of nicotine. Nature 1998; 391: 73-7.
26. Bierut LJ, Madden P, Breslau N, et al. Novel genes identified in ahigh density genome wide association study for nicotine depend-ence. Hum Mol Genet 2007; 16: 24-35.
27. Thorgeirsson TE, Geller F, Sulem P, et al. A variant associated with nicotine dependence, lung cancer and peripheral arterial dis-ease. Nature 2008; 452: 38-42.
28. Bierut LJ, Stitzel JA, Wang JC, et al. Variants in the Nicotinic Receptors and Risk for Nicotine Dependence. Am J Psychiatry 2008; 165: 1163-71.
29. Berrettini W, Yuan X, Tozzi F, et al. alpha-5/alpha-3 nicotinicreceptor subunit alleles increase risk for heavy smoking. Mol Psy-chiatry 2008; 13: 368-73.
30. McClure-Begley TD, King NM, Collins AC, Stitzel JA, WehnerJM, Butt CM. Acetylcholine-stimulated [3H]GABA release frommouse brain synaptosomes is modulated by alpha4beta2 and al-pha4alpha5beta2 nicotinic receptor subtypes. Mol Pharmacol 2009;75: 918-26.
31. Zoli M, Moretti M, Zanardi A, McIntosh JM, Clementi F, Gotti C.Identification of the nicotinic receptor subtypes expressed on do-paminergic terminals in the rat striatum. J Neurosci 2002; 22:8785-9.
32. Salminen O, Murphy KL, McIntosh JM, Drago J, Marks MJ,Collins AC, Grady SR. Subunit composition and pharmacology of two classes of striatal presynaptic nicotinic acetylcholine receptors mediating dopamine release in mice. Mol Pharmacol 2004; 65:1526-35.
33. Saccone SF, Hinrichs AL, Saccone NL, et al. Cholinergic nicotinic receptor genes implicated in a nicotine dependence associationstudy targeting 348 candidate genes with 3713 SNPs. Hum MolGenet 2007; 16: 36-49.
34. Grucza RA, Wang JC, Stitzel JA, et al. A risk allele for nicotine dependence in CHRNA5 is a protective allele for cocaine depend-ence. Biol Psychiatry 2008; 64: 922-9.
35. Kuryatov A, Onksen J, Lindstrom J. Roles of accessory subunits inalpha4beta2(*) nicotinic receptors. Mol Pharmacol 2008; 74: 132-43.
36. [36] Brown R, Collins AC, Lindstrom JM, Whiteaker P. Nicotinic al-pha5 subunit deletion locally reduces high-affinity agonist activa-tion without altering nicotinic receptor numbers. J Neuro chem 2007; 103: 204-15.
37. Wang JC, Grucza R, Cruchaga C, et al. Genetic variation in the CHRNA5 gene affects mRNA levels and is associated with risk for alcohol dependence. Mol Psychiatry 2009; 14: 501-10.
38. Zhang Y, Wang D, Johnson AD, Papp AC, Sadee W. Allelic ex-pression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G. J Biol Chem 2005; 280: 32618-24.
39. Bergen AW, Kokoszka J, Peterson R, et al. Mu opioid receptor gene variants: lack of association with alcohol dependence. Mol Psychiatry 1997; 2: 490-94.
40. Bond C, LaForge KS, Tian M, et al. Single-nucleotide polymor-phism in the human mu opioid receptor gene alters -endorphin binding and activity: possible implications for opiate addiction. Proc Natl Acad Sci USA 1998; 95: 9608-13.
41. Beyer A, Koch T, Schröder H,Schulz S, Höllt V. Effect of the A118G polymorphism on binding affinity, potency and agonist-mediated endocytosis, desensitization, and resensitization of the human μ-opioid receptor. J Neurochem 2004; 89: 553-60.
42. Ray LA, Hutchinson KE. A polymorphism of the -opioid receptor gene (OPRM1) and sensitivity to the effects of alcohol in humans. Alcohol Clin Exp Res 2004; 28: 1789-95.
43. van den Wildenberg E, Wiers RW, Dessers J, et al. A functional polymorphism of the -opioid receptor gene (OPRM1) influencescue-induced craving for alcohol in male heavy drinkers. Alcohol Clin Exp Res 2007; 31: 1-10.
44. Arias A, Feinn R, Kranzler HR. Association of an Asn40Asp (A118G) polymorphism in the -opioid receptor gene with sub-stance dependence: a meta-analysis. Drug Alcohol Depend 2006;83: 262-68.
45. Zubieta J-K, Dannals RF, Frost JJ. Gender and age influences on human brain mu-opioid receptor binding measured by PET. Am J Psychiatry 1999; 156: 842-8.
46. [46] Olive MF, Koenig HN, Nannini MA, Hodge CW. Stimulation of endorphin neuro-transmission in the nucleus accumbens by ethanol,cocaine, and amphetamine. J Neuro sci 2001; 21: RC184.
47. Marinelli PW, Bai L, Quirion R, Gianoulakis C. A microdialysis profile of Met- enkephalin release in the rat nucleus accumbens fol-lowing alcohol administration. Alcohol Clin Exp Res 2005; 29:1821-28.
48. Bencherif B, Wand GS, McCaul ME, et al. Mu- opioid receptor binding measured by [11C]carfentanil positron emission tomogra-phy is related to craving and mood in alcohol dependence. BiolPsychiatry 2004; 55: 255-62.
49. Oslin DW, Berrettini W, Kranzler HR, et al. A functional polymor-phism on the -opioid receptor gene is associated with naltrexoneresponse in alcohol-dependent patients. Neuropsychopharmacology 2003; 28: 1546-52.
50. Anton RF, Oroszi G, O'Malley S, et al. An evaluation of μ-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence. Arch Gen Psychiatry 2008; 65:135-44.
51. Gelernter J, Gueorguieva R, Kranzler HR, et al. Opioid receptor gene (OPRM1, OPRK1, and OPRD1) variants and response to naltrexone treatment for alcohol dependence: results from the VA Cooperative Study. Alcohol Clin Exp Res 2007; 31: 555-63.
52. Barr CS, Schwandt M, Lindell SG, et al. Association of a func-tional polymorphism in the -opioid receptor gene with alcohol re-sponse and consumption in male rhesus macaques. Arch Gen Psy-chiatry 2007; 64: 369-76.
53. Kessler RC, Crum RM, Warner LA, Nelson CB, Schulenberg J,Anthony JC. Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the NationalComorbidity Survey. Arch Gen Psychiatry 1997; 54: 313-21.
54. Merikangas, KR, Mehta RL, Molnar BE, et al. Comorbidity of substance use disorders with mood and anxiety disorders: results of the International Consortium in Psychiatric Epidemiology Addict Behav 1998; 23: 893-907.
55. Grant BF, Stinson FS, Dawson DA, et al. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry 2004; 61:807-16.
56. Grant BF, Stinson FS, Dawson DA, Chou SP, Ruan WJ, Pickering RP. Co-occurrence of 12-month alcohol and drug use disorders and personality disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry 2004; 61: 361-8.
57. Gottesman II, Gould TD. The endophenotype concept in psychiatry: etymology and strategic intentions Am J Psychiatry 2003; 160:636-45.
58. Hu X, Oroszi G, Chun J, Smith TL, Goldman D, Schuckit MA. An expanded evaluation of the relationship of four alleles to the level of response to alcohol and the alcoholism risk. Alcohol Clin Exp Res 2005; 29: 8-16.
59. Eysenck SB, Eysenck HJ. The place of impulsivity in a dimen-sional system of personality description. Br J Soc Clin Psychol 1977; 16: 57-68.
60. Winstanley CA, Eagle DM, Robbins TW. Behavioral models of impulsivity in relation to ADHD: Translation between clinical and reclinical studies. Clin Psychol Rev 2006; 26: 379-95.
61. Kendler KS, Prescott CA, Myers J, Neale MC. The structure of genetic and environmental risk factors for common psychiatric and substance use disorders in men and women. Arch Gen Psychiatry 2003; 60: 929-37.
62. King SM, Iacono WG, McGue M. Childhood externalizing and internalizing psychopathology in the prediction of early substance use. Addiction 2004; 99: 1548-59.
63. Krueger RF, Hicks BM, Patrick CJ, Carlson SR, Iacono WG,McGue M. Etiologic connections among substance dependence,antisocial behavior, and personality: modeling the externalizing spectrum. J Abnorm Psychol 2002; 111: 411-24.
64. Hicks BM, Krueger RF, Iacono WG, McGue M, Patrick CJ. Family transmission and heritability of externalizing disorders: a twin- family study. Arch Gen Psychiatry 2004; 61: 922-28.
65. Faraone SV, Perlis RH, Doyle AE, et al. Molecular genetics of attention deficit/hyperactivity disorder. Biol Psychiatry 2005; 57:1313-23.
66. Neale BM, Lasky-Su J, Anney R et al. Genome-wide association scan of attention deficit hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet 2008; 147B: 1337-44.
67. Franke P, Nothen MM, Wang T, et al. DRD4 exon III VNTRpolymorphism susceptibility factor for heroin dependence? Resultsof a case-control and a family-based association approach. Mol Psychiatry 2000; 5: 101-4.
68. Everitt BJ, Belin D, Economidou D, Pelloux Y, Dalley JW,Robbins TW. Review. Neural mechanisms underlying the vulner-ability to develop compulsive drug-seeking habits and addiction.Philos Trans R Soc Lond B Biol Sci 2008; 363: 3125-35.
69. Cases O, Lebrand C, Giros B, et al. Plasma membrane transportersof serotonin, dopamine, and norepinephrine mediate serotonin ac-cumulation in atypical locations in the developing brain of mono-amine oxidase A knock-outs. J Neurosci 1998; 18: 6914-27.
70. Brunner HG, Nelen M, Breakefield XO, Ropers HH, van Oost BA. Abnormal behavior associated with a point mutation in the struc-tural gene for monoamine oxidase A. Science 1993; 262: 578-80.
71. Virkkunen M, Linnoila M. Brain serotonin, type II alcoholism and impulsive violence. J Stud Alcohol Suppl 1993; 11: 163-69.
72. Chiavegatto S, Dawson VL, Mamounas LA, Koliatsos VE, Dawson TM, Nelson RJ. Brain serotonin dysfunciton accounts for aggres-sion in male mice lacking neuronal nictric oxide synthase. Proc Natl Acad Sci USA 2001; 98: 1277-81.
73. Winstanley CA, Theobald DE, Dalley JW, Cardinal RN, Robbins TW. Double dissociation between serotonergic and dopaminergicmodulation of medial prefrontal and orbitofrontal cortex during a test of impulsive choice. Cereb Cortex 2006; 16: 106-14.
74. Caspi A, Sugden K, Moffitt TE, et al. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene.Science 2003; 301: 386-9.
75. Roy A, Hu XZ, Janal MN, Goldman D. Interaction between child-hood trauma and serotonin transporter gene variation in suicide. Neuropsychopharmacology 2007; 32: 2046-52.
76. Crabbe JC, Phillips TJ, Feller DJ, et al. Elevated alcohol consump-tion in null mutant mice lacking 5-HT1B serotonin receptors. Nat Genet 1996; 14: 98-101.
77. Lappalainen J et al. Linkage of antisocial alcoholism to the sero-tonin 5-HT 1B receptor gene in 2 populations. Arch. Gen. Psychia-try 1998; 55: 989-94.
78. Soyka M, Preuss UW, Koller G, Zill P, Bondy B. Association of 5-HT1B receptor gene and antisocial behavior and alcoholism. J Neu-ral Transm 2004; 111: 101-9.
79. Kranzler HR, Hernandez-Avila CA, Gelertner J. Polymorphism of the 5-HT1B receptor gene (HTR1B): strong within locus linkage disequilibrium without association to antisocial substance depend-ence. Neuropshychopharmacology 2002; 26: 115-22.
80. Kendler KS, Walters EE, Neale MC, Kessler RC, Heath AC, Eaves LJ. The structure of the genetic and environmental risk factors for six major psychiatric disorders in women. Phobia, generalized anxiety disorder, panic disorder, bulimia, major depression, and al- coholism. Arch Gen Psychiatry 1995; 52: 374-83.
81. Koob GF. Dynamics of Neuronal Circuits in Addiction: Reward,Antireward, and Emotional Memory. Pharmacopsychiatry 2009;42: S32-S41.
82. Yavich L, Forsberg MM, Karayiorgou M, Gogos JA, Mannisto PT.Site-specific role of catechol-O-methyltransferase in dopamine overflow within prefrontal cortex and dorsal striatum. J Neurosci 2007; 27: 10196-209.
83. Palmatier MA, Kang AM, Kidd KK. Global variation in the fre-quencies of functionally different catechol-O-methyltransferase al-leles. Biol Psychiatry 1999; 46: 557-67.
84. Scanlon PD, Raymond FA, Weinshilboum RM. Catechol-O-methyltransferase: thermolabile enzyme in erythrocytes of subjects homozygous for allele for low activity. Science 1979; 203: 63-5.
85. Chen J, Lipska BK, Halim N, et al. Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain. Am J Hum Genet 2004; 75: 807-21.
86. Barnett JH, Jones PB, Robbins TW, Muller U. Effects of the catechol-O methyltransferase Val158Met polymorphism on execu- tive function: a meta-analysis of the Wisconsin Card Sort Test in schizophrenia and healthy controls. Mol Psychiatry 2007; 12: 502-9.
87. Egan MF, Goldberg TE, Kolachana BS, et al. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci USA 2001; 98: 6917-22.
88. Malhotra AK, Kestler LJ, Mazzanti C, Bates JA, Goldberg T,Goldman D. A functional polymorphism in the COMT gene and performance on a test of prefrontal cognition. Am J Psychiatry 2002; 159: 652-4.
89. Goldberg TE, Egan MF, Gscheidle T, et al. Executive subprocesses in working memory: relationship to catechol-O-methyltransferase Val158Met genotype and schizophrenia. Arch Gen Psychiatry 2003; 60: 889-96.
90. Ducci F, Goldman D. Genetic approaches to addiction: genes and alcohol. Addiction 2008; 103: 1414-28.
91. Enoch MA, Xu K, Ferro E, Harris CR, Goldman D. Genetic origins of anxiety in women: a role for a functional catechol-O-methyltransferase polymorphism. Psychiatr Genet 2003; 13: 33-41.
92. Nackley AG, Shabalina SA, Tchivileva IE, et al. Human catechol-O-methyltransferase haplotypes modulate protein expression by al-tering mRNA secondary structure. Science 2006; 314: 1930-33.
93. Vandenbergh DJ, Rodriguez LA, Miller IT, Uhl GR, Lachman HM. High-activity catechol-O-methyltransferase allele is more prevalent in polysubstance abusers. Am J Med Genet 1997; 74:439-42
94. Tiihonen J, Hallikainen T, Lachman H, et al. Association between the functional variant of the catechol-O-methyltransferase (COMT)gene and type 1 alcoholism. Mol Psychiatry 1999; 4: 286-9.
95. Kauhanen J, Hallikainen T, Tuomainen TP, et al. Association be-tween the functional polymorphism of catechol-O-methyltransferase gene and alcohol consumption among social drinkers. Alcohol Clin Exp Res 2000; 24: 135-39.
96. Nestler EJ. Is there a common pathway for addiction? Nat Neurosci 2005; 8: 1445-49.
97. Di Chiara G, Bassareo V, Fenu S et al. Dopamine and drug addic-tion: the nucleus accumbens shell connection. Neuropharmacology 2004; 47: 227-41.
98. Xu K, Lichtermann D, Lipsky RH, et al. Association of specific haplotypes of D2 dopamine receptor gene with vulnerability to heroin dependence in 2 distinct populations. Arch Gen Psychiatry 2004; 61: 597-606.
99. Doyon WM, York JL, Diaz LM, Samson HH, Czachowski CL,Gonzales RA. Dopamine activity in the nucleus accumbens during consummatory phases of oral ethanol self-administration. Alcohol Clin Exp Res 2003; 27: 1573-82.
100. Ducci F, Enoch MA, Yuan Q, et al. HTR3B is associated with alcoholism with antisocial behavior and alpha EEG power-an in-termediate phenotype for alcoholism and co-morbid behaviors. Alcohol 2009; 43: 73-84.
101. Moffitt T E, Caspi A, Rutter M. Strategy for investigating interac-tions between measured genes and measured environments. Arch Gen Psychiatry 2005; 62: 473-81.
102. Cases O, Seif I, Grimsby J, et al. Aggressive behavior and altered amounts of brain serotonin and norepinephrine in mice lacking MAOA. Science 1995; 268: 1763-66.
103. Caspi A, McClay J, Moffitt TE, et al. Role of genotype in the cycle of violence in maltreated children. Science 2002; 297: 851-54.
104. Taylor A, Kim-Cohen J. Meta-analysis of gene-environment inter-actions in developmental psychopathology. Dev Psychopathol 2007; 19: 1029-37.
105. Ducci F, Enoch MA, Hodgkinson C, et al. Interaction between a functional MAOA locus and childhood sexual abuse predicts alco-holism and antisocial personality disorder in adult women. Mol Psychiatry 2007; 13: 334-47.
106. Ou XM, Chen K, Shih JC. Glucocorticoid and androgen activation of monoamine oxidase A is regulated differently by R1 and Sp1. J Biol Chem 2006; 281: 215-25.
107. Sjöberg RL, Ducci F, Barr CS, et al. A non-additive interaction of a functional MAO-A VNTR and testosterone predicts antisocial be-havior. Neuropsychopharmacology 2008; 33: 425-30.
108. Lesch KP, Bengel D, Heils A, et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regula- tory region. Science 1996; 274: 1527-31.
109. Hu XZ, Lipsky RH, Zhu G, et al. Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive dis-order. Am J Hum Genet 2006; 78: 815-26.
110. Feinn R, Nellissery M, Kranzler HR. Meta-analysis of the associa-tion of a functional serotonin transporter promoter polymorphism with alcohol dependence. Am J Med Genet B 2005; 133: 79-84.
111. Barr CS, Newman TK, Lindell S, et al. Interaction between sero-tonin transporter gene variation and rearing condition in alcohol preference and consumption in female primates. Arch Gen Psychia-try 2004; 61: 1146-52.
112. Bevilacqua L, Goldman D. Genes and addiction. Clin Pharmacol Ther 2009; 85: 359-61.
113. Liu QR, Walther D, Drgon T, et al. Human brain derived neurotro-phic factor (BDNF) genes, splicing patterns, and assessments of as-sociations with substance abuse and Parkinson's disease. Am J Med Genet B 2005; 134: 93-103.
114. Edenberg HJ. Variations in GABRA2, encoding the 2 subunit of the GABAA receptor, are associated with alcohol dependence and with brain oscillations. Am J Hum Genet 2004; 74: 705-14.
115. Zhou Z, Zhu G, Hariri AR, et al. Genetic variation in human NPY expression affects stress response and emotion. PLoS Nature 2008; 452: 997-1001.
116. Connor JP, Young RM, Lawford BR, Ritchie TL, Noble EP. D2 dopamine receptor (DRD2) polymorphism is associated with sever-ity of alcohol dependence. Eur Psychiatry 2002; 17: 17-23.
117. Salas R, Orr-Urtreger A, Broide RS, Beaudet A, Paylor R, De Biasi M. The nicotinic acetylcholine receptor subunit alpha 5 mediates short-term effects of nicotine in vivo. Mol Pharmacol 2003; 63:1059-66.
118. Salas R, Pieri F, De Biasi M. Decreased signs of nicotine with-drawal in mice null for the beta4 nicotinic acetylcholine receptor subunit. J Neurosci 2004; 24: 10035-9.
119. Salas R, Cook KD, Bassetto L, De Biasi M. The alpha3 and beta4 nicotinic acetylcholine receptor subunits are necessary for nicotine-induced seizures and hypolocomotion in mice. Neuropharmacology 2004; 47: 401-7.
120. Moore MS. Ethanol intoxication in Drosophila: genetic and phar-macological evidence for regulation by the cAMP signaling path-way. Cell 1998; 93: 997-1007.
121. Corl AB, Berger KH, Ophir-Shohat G, Gesch J, Simms JA, Bartlett SE, Heberlein U. Happyhour, a Ste20 family kinase, implicates EGFR signaling in ethanol-induced behaviors. Cell 2009; 137: 949-60.
122. Barr CS, Newman TK, Becker ML, et al. Serotonin transportergene variation is associated with alcohol sensitivity in rhesus ma-caques exposed to early-life stress. Alcohol Clin Exp Res 2003; 27:812-17.
123. Reich T, Edenberg HJ, Goate A, et al. Genome-wide search for genes affecting the risk for alcohol dependence. Am J Med Genet 1998; 81: 207-15.
124. Prescott CA, Sullivan PF, Kuo PH, et al. Genomewide linkage study in the Irish affected sib pair study of alcohol dependence:evidence for a susceptibility region for symptoms of alcohol dependence on chromosome 4. Mol Psychiatry 2006; 11: 603-11.
125. Long JC, Knowler WC, Hanson RL, et al. Evidence for genetic linkage to alcohol dependence on chromosomes 4 and 11 from an autosome-wide scan in an American Indian population. Am J Med Genet 1998; 81: 216-21.
126. Ehlers CL, Gilder DA, Wall TL, Phillips E, Feiler H, Wilhelmsen KC. Genomic screen for loci associated with alcohol dependence in Mission Indians. Am J Med Genet B Neuropsychiatr Genet 2004; 129: 110-15.
127. Edenberg HJ, Dick DM, Xuei X, et al. Variations in GABRA2, encoding the alpha 2 subunit of the GABA(A) receptor, are associ-ated with alcohol dependence and with brain oscillations. Am J Hum Genet 2004; 74: 705-14.
128. Fehr C, Sander T, Tadic A, et al. Confirmation of the association ofGABRA2 gene with alcohol dependence by subtype specific analy-sis. Psychiatr Genet 2006; 16: 9-17.
129. Radel M, Vallejo RL, Iwata N, et al. Haplotype-based localization of an alcohol dependence gene to the 5q34 {gamma}-aminobutyric acid type A gene cluster. Arch Gen Psychiatry 2005; 62: 47-55.
130. Crabbe JC, Phillips TJ, Buck KJ, Cunningham CL, Belknap JK. Identifying genes for alcohol and drug sensitivity: recent progress and future directions. Trends Neurosci 1999; 22: 173-9.
131. Korpi ER, Kleingoor C, Kettenmann H, Seeburg PH. Benzodi-azepine-induced motor impairment linked to point mutation in cerebellar GABAA receptor. Nature 1993; 361: 356-9.
132. Enoch MA, Schwartz L, Albaugh B, Virkkunen M, Goldman D. Dimensional anxiety mediates linkage of GABRA2 haplotypes with alcoholism. Am J Med Genet B Neuropsychiatr Genet 2006;141: 599-607.
133. Agrawal A, Pergadia ML, Saccone SF, et al. Gamma-aminobutyric acid receptor genes and nicotine dependence: evidence for associa-tion from a case-control study. Addiction 2008; 103: 1027-38.
134. Drgon T, D'Addario C, Uhl G. Linkage sidequilibrium, haplotype and association studies of a chromosome 4 GABA receptor gene cluster: candidate gene variants for addictions. Am J Med Genet B Neuropsychiatr Genet 2006; 141B: 854-60.
135. Agrawal A, Pergadia ML, Saccone SF, et al. An autosomal linkage scan for cannabis use disorders in the nicotine addiction genetics project. Arch Gen Psychiatry 2008; 65: 713-21.
136. Schuckit MA, Smith TL, Kalmijn J, Tsuang J, Hesselbrock V, Bucholz K. Response to alcohol in daughters of alcoholics: a pilot study and a comparison with sons of alcoholics. Alcohol Alcohol 2000; 35: 242-8.
137. Porjesz B, Begleiter H, Wang K, et al. Linkage and linkage dise-quilibrium mapping of ERP and EEG phenotypes. Biol Psychol 2002; 61: 229-48.
138. Enoch MA, Shen PH, Ducci F, et al. Common genetic origins for EEG, alcoholism and anxiety: the role of CRH-BP. PLoS One 2008; 3: e3620.
139. Uhl GR, Drgon T, Liu Q-R, et al. Genome-wide association for methamphetamine dependence: convergent results from 2 samples.Arch Gen Psychiatry 2008; 65: 345-55.
140. Ng SB, Turner EH, Robertson PD, et al. Targeted capture and massively parallel sequencing of 12 human exomes. Nature 2009;461(7261): 272-6.
141. Tarpey PS, Smith R, Pleasance E, et al. A systematic, large-scale resequencing screen of X-chromosome coding exons in mental re-tardation. Nature 2009; 41: 535-43.
142. Johnson C, Drgon T, Liu QR, et al. Pooled association genome scanning for alcohol dependence using 104,268 SNPs: validation and use to identify alcoholism vulnerability loci in unrelated indi-viduals from the collaborative study on the genetics of alcoholism. Am J Med Genet B Neuropsychiatr Genet 2006; 141B: 844-53.
143. Nurnberger JI Jr, Foroud T, Flury L, et al. Evidence for a locus on chromosome 1 that influences vulnerability to alcoholism and af-fective disorder. Am J Psychiatry 2001; 158: 718-24.
144. Uhl G, Drgon T, Johnson C, Fatusin O, et al. "Higher order" addic-tion molecular genetics: Convergent data from genome-wide asso-ciation in humans and mice. Biochem Pharmacol 2008; 75: 98-111.
145. Kumar A, Choi KH, Renthal W, et al. Chromatin remodeling is a key mechanism underlying cocaine-induced plasticity in striatum. Neuron 2005; 48: 303-14.
146. Freeman WM, Patel KM, Brucklacher RM, et al. Persistent altera-tions in mesolimbic gene expression with abstinence from cocaine self-administration. Neuropsychopharmacology 2007; 33: 1807-17.
147. Renthal W, Maze I, Krishnan V, et al. Histone deacetylase 5 epige-netically controls behavioral adaptations to chronic emotional stimuli. Neuron 2007; 447: 433-440.
148. Renthal W, Kumar A, Xiao G, et al. Genome-wide analysis of chromatin regulation by cocaine reveals a role for sirtuins. Neuron 2009; 62: 335-48.